Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

FHS
June 18, 2024
11:43 pm

A recent study from the PIONEER REAL Netherlands trial demonstrated that oral semaglutide effectively manages type 2 diabetes and supports weight loss in adults.

Unexplained Heart Enlargement May Be Causing Sudden Deaths in Obesity

Obesity cardiomyopathy (OCM) was identified as a distinct pathology associated with sudden cardiac death (SCD) based on records from a national referral center in the

July 29, 2023

Aligos Therapeutics sees highest filings and grants during October in Q4 2023

Share this article Aligos Therapeutics has been focused on protecting inventions in United States(US) with ten publications in Q4 2023 The United States(US) Patent Office

February 27, 2024

Majority of naloxone recipients in NYC at high risk of overdose

The overwhelming majority of those in New York City who obtained a naloxone kit to counteract opioid overdose had a high need for the drug,

January 16, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.